However, there is currently no evidence that bronchial epithelial-derived TSLP induced by SARS-CoV-2 contributes to the development of autoimmunity or other chronic inflammatory diseases, and these aspects will have to be investigated further. The gene discussed is TSLP; the disease is Autoimmunity.